SR
Satyam Reddy Gopidi
About Satyam Reddy Gopidi
Data last updated:
Satyam Reddy Gopidi is a Director at Concord Drugs Limited (since 2025). The company operates in Pharma. Concord Drugs Limited reported revenue of ₹45.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Concord Drugs Limited L24230TG1995PLC020093 | Director | 30 Sep 2025 | 1995 | ₹45.26 Cr (FY 2025) | Active |
Board colleagues of Satyam Reddy Gopidi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Koni Reddy Seelam | 02829319 | Concord Drugs Limited | Whole-Time Director |
| Koni Reddy Seelam | Concord Drugs Limited | Cfo | |
| Nagavenkatahareeshkumar Solleti | 09066790 | Concord Drugs Limited | Director |
| Nagi Reddy Seelam | 01764665 | Concord Drugs Limited | Managing Director |
| Namratha | Concord Drugs Limited | Company Secretary | |
| Seelam Manojkumarreddy | 06991382 | Concord Drugs Limited | Whole-Time Director |
| Sumeela Kasu | 09571540 | Concord Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyam Reddy Gopidi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyam Reddy Gopidi
Satyam Reddy Gopidi currently holds 1 directorship: Concord Drugs Limited (Director, since 30 Sep 2025, revenue ₹45.26 Cr (FY 2025)).
Satyam Reddy Gopidi was first appointed on 30 Sep 2025 as Director at Concord Drugs Limited.
The current boards of Satyam Reddy Gopidi's companies include Koni Reddy Seelam (Concord Drugs Limited), Koni Reddy Seelam (Concord Drugs Limited), Nagavenkatahareeshkumar Solleti (Concord Drugs Limited), Nagi Reddy Seelam (Concord Drugs Limited), Namratha (Concord Drugs Limited), Seelam Manojkumarreddy (Concord Drugs Limited), among others.